mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
4e-06 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
5e-05 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
6e-05 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
9e-05 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
mRNA |
XMD11-85h |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
0.0001 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
0.22 |
0.0002 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |